| abstract |
“ANTIBODIES, CANCER TREATMENT METHODS ANDnPRODUCTION OF AN ANTIBODY, NUCLEIC ACID, VECTOR, CELLSnHOSTELS AND PHARMACEUTICAL COMPOSITION ”. The present disclosure is generally directed to compositions that include antibodies, for example, monoclonal antibodies, antibody fragments, etc., which specifically bind to a SIRPA polypeptide, for example, mammalian SIRPA or human SIRPA, and the use of these compositions in the prevention, risk reduction, or treatment of an individual with such a need. |